-+ 0.00%
-+ 0.00%
-+ 0.00%

Evotec Nominates Preclinical Development Candidate From Almirall Collaboration Targeting Immune-Mediated Inflammatory Skin Diseases

Benzinga·05/04/2026 05:54:38
Listen to the news
  • Joint Evotec-Almirall team advances small molecule program to preclinical development significantly outperforming standard industry timelines
  • Collaboration leverages Evotec's end-to-end integrated AI/ML-driven R&D capabilities and Almirall's dermatology expertise